Last reviewed · How we verify
bevacizumab, everolimus, panitumumab
bevacizumab, everolimus, panitumumab is a Small molecule drug developed by Herbert Hurwitz, MD. It is currently in Phase 1 development. Also known as: avastin, RAD001.
At a glance
| Generic name | bevacizumab, everolimus, panitumumab |
|---|---|
| Also known as | avastin, RAD001 |
| Sponsor | Herbert Hurwitz, MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) (PHASE1)
- BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- bevacizumab, everolimus, panitumumab CI brief — competitive landscape report
- bevacizumab, everolimus, panitumumab updates RSS · CI watch RSS
- Herbert Hurwitz, MD portfolio CI
Frequently asked questions about bevacizumab, everolimus, panitumumab
What is bevacizumab, everolimus, panitumumab?
bevacizumab, everolimus, panitumumab is a Small molecule drug developed by Herbert Hurwitz, MD.
Who makes bevacizumab, everolimus, panitumumab?
bevacizumab, everolimus, panitumumab is developed by Herbert Hurwitz, MD (see full Herbert Hurwitz, MD pipeline at /company/herbert-hurwitz-md).
Is bevacizumab, everolimus, panitumumab also known as anything else?
bevacizumab, everolimus, panitumumab is also known as avastin, RAD001.
What development phase is bevacizumab, everolimus, panitumumab in?
bevacizumab, everolimus, panitumumab is in Phase 1.
Related
- Manufacturer: Herbert Hurwitz, MD — full pipeline
- Also known as: avastin, RAD001
- Compare: bevacizumab, everolimus, panitumumab vs similar drugs
- Pricing: bevacizumab, everolimus, panitumumab cost, discount & access